tiprankstipranks
Analyst Profile
Followed by 655 other investors
.
Puneet Souda

Puneet Souda

SVB Securities
Wall Street Analyst
Ranked #7,764 out of 8,045 Analysts on TipRanks (#20,647 out of 21,519 overall experts)

Success Rate

42%
147 out of 348 Profitable Transactions

Average Return

-6.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Puneet Souda's ratings since 2014 and opened each position for the duration of 1 Year:
42.24% of your transactions would have been profitable with an average return of -6.3%

Stock Rating Distribution

493Ratings
85.60% Buy
14.40% Hold
0.00% Sell
Distribution of Puneet Souda's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
CryoPort Inc
(CYRX)
Rating Type:Buy
Dates:Nov 08, 2019 - Nov 08, 2020
Gain:225.20%
The most profitable rating made by Puneet Souda

Puneet Souda's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
Baxter International
Oct 20, 2014
Buy
Reiterated
$80.00
(28.99% Upside)
0%
-4.70%
1
PTHN
Patheon NV
Jun 09, 2017
Hold
Downgraded
0.00%
1
T2 Biosystems
Aug 24, 2021
Buy
Reiterated
$3.00
(1361.99% Upside)
0%
-69.53%
9
HTG Molecular Diagnostics
Aug 24, 2021
Buy
Reiterated
$10.00
(843.40% Upside)
0%
-71.47%
7
Galecto
Apr 29, 2022
Buy
Reiterated
$16.00
(644.19% Upside)
100%
+28.50%
1
Olink Holding
Jul 14, 2022
Buy
Reiterated
$25.00
(42.13% Upside)
44%
-16.97%
13
Abcam
Jul 14, 2022
Buy
Reiterated
$25.00
(60.15% Upside)
29%
-9.03%
9
Agilent
Jul 14, 2022
Buy
Reiterated
$145.00
(8.29% Upside)
75%
+18.34%
17
Centogene NV
Jul 15, 2022
Buy
Reiterated
$6.00
(237.08% Upside)
0%
-66.66%
10
Hologic
Jul 27, 2022
Buy
Reiterated
$85.00
(15.69% Upside)
83%
+0.95%
7
List of latest recommendations made by Puneet Souda. Click to expand and see Puneet Souda's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More